160 related articles for article (PubMed ID: 24378346)
1. Candesartan and glycyrrhizin ameliorate ischemic brain damage through downregulation of the TLR signaling cascade.
Barakat W; Safwet N; El-Maraghy NN; Zakaria MN
Eur J Pharmacol; 2014 Feb; 724():43-50. PubMed ID: 24378346
[TBL] [Abstract][Full Text] [Related]
2. Glycyrrhizin protects brain against ischemia-reperfusion injury in mice through HMGB1-TLR4-IL-17A signaling pathway.
Zhang J; Wu Y; Weng Z; Zhou T; Feng T; Lin Y
Brain Res; 2014 Sep; 1582():176-86. PubMed ID: 25111887
[TBL] [Abstract][Full Text] [Related]
3. Comparison between early and delayed systemic treatment with candesartan of rats after ischaemic stroke.
Brdon J; Kaiser S; Hagemann F; Zhao Y; Culman J; Gohlke P
J Hypertens; 2007 Jan; 25(1):187-96. PubMed ID: 17143191
[TBL] [Abstract][Full Text] [Related]
4. Ruscogenin reduces cerebral ischemic injury via NF-κB-mediated inflammatory pathway in the mouse model of experimental stroke.
Guan T; Liu Q; Qian Y; Yang H; Kong J; Kou J; Yu B
Eur J Pharmacol; 2013 Aug; 714(1-3):303-11. PubMed ID: 23911884
[TBL] [Abstract][Full Text] [Related]
5. Comparison of inhibitory action of candesartan and enalapril on brain ischemia through inhibition of oxidative stress.
Hamai M; Iwai M; Ide A; Tomochika H; Tomono Y; Mogi M; Horiuchi M
Neuropharmacology; 2006 Sep; 51(4):822-8. PubMed ID: 16824557
[TBL] [Abstract][Full Text] [Related]
6. Hypertension after experimental cerebral ischemia: candesartan provides neurovascular protection.
Fagan SC; Kozak A; Hill WD; Pollock DM; Xu L; Johnson MH; Ergul A; Hess DC
J Hypertens; 2006 Mar; 24(3):535-9. PubMed ID: 16467657
[TBL] [Abstract][Full Text] [Related]
7. LPS preconditioning redirects TLR signaling following stroke: TRIF-IRF3 plays a seminal role in mediating tolerance to ischemic injury.
Vartanian KB; Stevens SL; Marsh BJ; Williams-Karnesky R; Lessov NS; Stenzel-Poore MP
J Neuroinflammation; 2011 Oct; 8():140. PubMed ID: 21999375
[TBL] [Abstract][Full Text] [Related]
8. Effect of combined treatment with curcumin and candesartan on ischemic brain damage in mice.
Awad AS
J Stroke Cerebrovasc Dis; 2011 Nov; 20(6):541-8. PubMed ID: 20719539
[TBL] [Abstract][Full Text] [Related]
9. Berberine attenuates ischemia-reperfusion injury through inhibiting HMGB1 release and NF-κB nuclear translocation.
Zhu JR; Lu HD; Guo C; Fang WR; Zhao HD; Zhou JS; Wang F; Zhao YL; Li YM; Zhang YD; Yang CQ; Sun JG
Acta Pharmacol Sin; 2018 Nov; 39(11):1706-1715. PubMed ID: 30266998
[TBL] [Abstract][Full Text] [Related]
10. Targeted acetylation of NF-kappaB/RelA and histones by epigenetic drugs reduces post-ischemic brain injury in mice with an extended therapeutic window.
Lanzillotta A; Pignataro G; Branca C; Cuomo O; Sarnico I; Benarese M; Annunziato L; Spano P; Pizzi M
Neurobiol Dis; 2013 Jan; 49():177-89. PubMed ID: 22971966
[TBL] [Abstract][Full Text] [Related]
11. Candesartan but not ramipril pretreatment improves outcome after stroke and stimulates neurotrophin BNDF/TrkB system in rats.
Krikov M; Thone-Reineke C; Müller S; Villringer A; Unger T
J Hypertens; 2008 Mar; 26(3):544-52. PubMed ID: 18300867
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effect of erythropoietin, and role of metallothionein-1 and -2, in permanent focal cerebral ischemia.
Wakida K; Shimazawa M; Hozumi I; Satoh M; Nagase H; Inuzuka T; Hara H
Neuroscience; 2007 Aug; 148(1):105-14. PubMed ID: 17624681
[TBL] [Abstract][Full Text] [Related]
13. Cerebroprotective effects of TAK-937, a cannabinoid receptor agonist, on ischemic brain damage in middle cerebral artery occluded rats and non-human primates.
Suzuki N; Suzuki M; Murakami K; Hamajo K; Tsukamoto T; Shimojo M
Brain Res; 2012 Jan; 1430():93-100. PubMed ID: 22119394
[TBL] [Abstract][Full Text] [Related]
14. The angiotensin II type 1-receptor blocker candesartan increases cerebral blood flow, reduces infarct size, and improves neurologic outcome after transient cerebral ischemia in rats.
Engelhorn T; Goerike S; Doerfler A; Okorn C; Forsting M; Heusch G; Schulz R
J Cereb Blood Flow Metab; 2004 Apr; 24(4):467-74. PubMed ID: 15087716
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotection of early and short-time applying atorvastatin in the acute phase of cerebral ischemia: down-regulated 12/15-LOX, p38MAPK and cPLA2 expression, ameliorated BBB permeability.
Cui L; Zhang X; Yang R; Wang L; Liu L; Li M; Du W
Brain Res; 2010 Apr; 1325():164-73. PubMed ID: 20167207
[TBL] [Abstract][Full Text] [Related]
16. Study of Neuroprotection by a Combination of the Biological Antioxidant (
Trabolsi C; Takash Chamoun W; Hijazi A; Nicoletti C; Maresca M; Nasser M
Molecules; 2021 Feb; 26(4):. PubMed ID: 33562701
[TBL] [Abstract][Full Text] [Related]
17. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
[TBL] [Abstract][Full Text] [Related]
18. Comparison between single and combined treatment with candesartan and pioglitazone following transient focal ischemia in rat brain.
Schmerbach K; Schefe JH; Krikov M; Müller S; Villringer A; Kintscher U; Unger T; Thoene-Reineke C
Brain Res; 2008 May; 1208():225-33. PubMed ID: 18378216
[TBL] [Abstract][Full Text] [Related]
19. Oxymatrine downregulates TLR4, TLR2, MyD88, and NF-kappaB and protects rat brains against focal ischemia.
Fan H; Li L; Zhang X; Liu Y; Yang C; Yang Y; Yin J
Mediators Inflamm; 2009; 2009():704706. PubMed ID: 20182634
[TBL] [Abstract][Full Text] [Related]
20. Cooperative effect of angiotensin AT(1) and endothelin ET(A) receptor antagonism limits the brain damage after ischemic stroke in rat.
Stenman E; Jamali R; Henriksson M; Maddahi A; Edvinsson L
Eur J Pharmacol; 2007 Sep; 570(1-3):142-8. PubMed ID: 17597600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
